Regulatory document
Withdrawal of indication for Olaparib Tablets 100mg and 150mg in the treatment of patient…
CDSCO · Information · India
Key facts
| Title | Withdrawal of indication for Olaparib Tablets 100mg and 150mg in the treatment of patient with gBRCA mutution and advanced ovarian cancer who have been treated with three or more prior lines of chemotherapy |
|---|---|
| Issuer | Central Drugs Standard Control Organization |
| Source | CDSCO |
| Document type | Information |
| Country or region | India |
| Document | cdsco.gov.in |
| Issuer website | cdsco.gov.in |
At a glance
- Yes Full text searchable in Orca1
- 1,000+ Documents from this issuer in Orca1
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Global regulations and guidance
Regulations, guidance and official notices from medical device and medicines regulators worldwide, collected by Orca1 from each issuer's website. Only the title, issuer, date and link are shown here; the full text is searchable in Orca1.